Pepdox
Studies
Peptides
Calculator
Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia. | Pepdox
Home
/
Search
/
PMID 38720915
Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia.
The Canadian journal of hospital pharmacy
2024
PMID: 38720915
View on PubMed
DOI: 10.4212/cjhp.3534
Case Report
Semaglutide
Authors
Dobson, Raea